Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of NIPPON KAYAKU CO.,LTD.. A complete text table follows the diagram.
Life Science profit jumped 48.1% to ¥5.3B, while Mobility fell 25.9% despite modest sales growth.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Life Science Business Unit | 1 | 5.3B | 34.3% of reported total |
| Mobility & Imaging Business Unit | 1 | 5.2B | 33.6% of reported total |
| Fine Chemicals Business Unit | 1 | 5.0B | 32.1% of reported total |
| Gross operating income | 2 | 15.5B | Reported six-month total · ¥15.5B |
| Operating Income | 3 | 10.6B | Reported consolidated total |
| Eliminations & reconciliation | 3 | 4.9B | Reported dimensional reconciliation |
| Profit before tax | 4 | 16.6B | Reported pretax result |
| Net non-operating income | 3 | 6.0B | Arithmetic bridge to reported pretax profit |
| Net profit attributable to owners | 5 | 11.7B | Reported parent-company result |
| Tax, attribution & other | 5 | 4.9B | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Life Science Business Unit | Gross operating income | 5.3B |
| Mobility & Imaging Business Unit | Gross operating income | 5.2B |
| Fine Chemicals Business Unit | Gross operating income | 5.0B |
| Gross operating income | Operating Income | 10.6B |
| Gross operating income | Eliminations & reconciliation | 4.9B |
| Operating Income | Profit before tax | 10.6B |
| Net non-operating income | Profit before tax | 6.0B |
| Profit before tax | Net profit attributable to owners | 11.7B |
| Profit before tax | Tax, attribution & other | 4.9B |